LTFS
PDLI

Ladenburg Thalmann Financial Services’s PDL BioPharma, Inc. PDLI Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$10K Hold
3,169
– – ﹤0.01% 4509
2019
Q3 		$6K Buy
3,169
+8
+0.3% +$21 ﹤0.01% 4657
2019
Q2 		$9K Sell
3,161
-14,964
-83% -$48.5K ﹤0.01% 4508
2019
Q1 		$67K Hold
18,125
– – ﹤0.01% 3201
2018
Q4 		$52K Sell
18,125
-1,017
-5% -$2.79K ﹤0.01% 3223
2018
Q3 		$50K Sell
19,142
-5,000
-21% -$12.3K ﹤0.01% 3320
2018
Q2 		$71K Hold
24,142
– – ﹤0.01% 3017
2018
Q1 		$71K Buy
24,142
+3,125
+15% +$8.53K ﹤0.01% 3017
2017
Q4 		$58K Hold
21,017
– – ﹤0.01% 3128
2017
Q3 		$71K Hold
21,017
– – ﹤0.01% 2838
2017
Q2 		$52K Hold
21,017
– – ﹤0.01% 3004
2017
Q1 		$48K Buy
21,017
+19,547
+1,330% +$43.2K ﹤0.01% 2952
2016
Q4 		$3K Sell
1,470
-10,700
-88% -$29.9K ﹤0.01% 4495
2016
Q3 		$41K Sell
12,170
-443
-4% -$1.41K ﹤0.01% 2951
2016
Q2 		$40K Buy
12,613
+744
+6% +$2.48K ﹤0.01% 2865
2016
Q1 		$40K Sell
11,869
-5,406
-31% -$16.9K ﹤0.01% 2761
2015
Q4 		$61K Sell
17,275
-2,808
-14% -$11.8K ﹤0.01% 2424
2015
Q3 		$101K Buy
20,083
+1,127
+6% +$6.46K ﹤0.01% 1983
2015
Q2 		$121K Buy
18,956
+22
+0.1% +$147 ﹤0.01% 1965
2015
Q1 		$132K Buy
18,934
+1,539
+9% +$11.1K ﹤0.01% 1883
2014
Q4 		$134K Buy
17,395
+5,446
+46% +$43.1K ﹤0.01% 1697
2014
Q3 		$89K Buy
11,949
+857
+8% +$7.96K ﹤0.01% 1671
2014
Q2 		$107K Sell
11,092
-1,944
-15% -$17.3K ﹤0.01% 1566
2014
Q1 		$108K Sell
13,036
-1,080
-8% -$9.26K ﹤0.01% 1473
2013
Q4 		$119K Sell
14,116
-1,454
-9% -$12.3K ﹤0.01% 1359
2013
Q3 		$125K Sell
15,570
-153
-1% -$1.23K ﹤0.01% 1265
2013
Q2 		$122K Buy
+15,723
New +$123K ﹤0.01% 1215

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ladenburg Thalmann Financial Services's PDLI Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its PDL BioPharma, Inc. (PDLI) position steady in Q4 2019 at 3,169 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #4509.

Ladenburg Thalmann Financial Services first reported a position in PDLI in Q2 2013 and has held it in 27 quarters since. The position peaked at $134K in Q4 2014. 150 funds tracked by Wall St. Rank hold PDLI as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 3,169 shares of PDL BioPharma, Inc. worth $10K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its PDL BioPharma, Inc. share count unchanged in Q4 2019.
  • PDL BioPharma, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4509 holding.
  • Ladenburg Thalmann Financial Services first reported a position in PDL BioPharma, Inc. in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's PDL BioPharma, Inc. position peaked at $134K in Q4 2014.
  • 150 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.